JPS60120817A - 医療用組成物 - Google Patents

医療用組成物

Info

Publication number
JPS60120817A
JPS60120817A JP59198764A JP19876484A JPS60120817A JP S60120817 A JPS60120817 A JP S60120817A JP 59198764 A JP59198764 A JP 59198764A JP 19876484 A JP19876484 A JP 19876484A JP S60120817 A JPS60120817 A JP S60120817A
Authority
JP
Japan
Prior art keywords
composition
composition according
amount
generating
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59198764A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6254775B2 (enExample
Inventor
ジヨン　レオナード　カントレル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIBI IMIYUNOKEMU RESEARCH Inc
Original Assignee
RIBI IMIYUNOKEMU RESEARCH Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIBI IMIYUNOKEMU RESEARCH Inc filed Critical RIBI IMIYUNOKEMU RESEARCH Inc
Publication of JPS60120817A publication Critical patent/JPS60120817A/ja
Publication of JPS6254775B2 publication Critical patent/JPS6254775B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59198764A 1983-09-23 1984-09-25 医療用組成物 Granted JPS60120817A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use
US535037 1983-09-23

Publications (2)

Publication Number Publication Date
JPS60120817A true JPS60120817A (ja) 1985-06-28
JPS6254775B2 JPS6254775B2 (enExample) 1987-11-17

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59198764A Granted JPS60120817A (ja) 1983-09-23 1984-09-25 医療用組成物

Country Status (23)

Country Link
US (1) US4663306A (enExample)
JP (1) JPS60120817A (enExample)
KR (1) KR870000843B1 (enExample)
AT (1) AT385659B (enExample)
AU (1) AU566234B2 (enExample)
BE (1) BE900650A (enExample)
CA (1) CA1244765A (enExample)
CH (1) CH664897A5 (enExample)
DE (1) DE3434766C2 (enExample)
DK (1) DK446684A (enExample)
ES (1) ES8608872A1 (enExample)
FI (1) FI843716L (enExample)
FR (1) FR2552326B1 (enExample)
GB (1) GB2149301B (enExample)
HU (1) HU192585B (enExample)
IL (1) IL73034A (enExample)
IN (1) IN157240B (enExample)
IT (1) IT1179444B (enExample)
NL (1) NL8402902A (enExample)
NO (1) NO843776L (enExample)
NZ (1) NZ209635A (enExample)
SE (1) SE8404707L (enExample)
ZA (1) ZA847405B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000003724A1 (en) * 1998-07-16 2000-01-27 Hayashi, Akira Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
CA2170142C (en) * 1993-08-27 2010-05-25 Jose M. Wade Composition and method for stimulation of reproductive performance
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
DK1003525T3 (da) 1997-08-05 2003-03-24 Bioniche Life Sciences Inc Præparat og fremgangsmåde til regulering af celleproliferation og celledød
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
CN100445380C (zh) * 1999-12-13 2008-12-24 拜昂尼科生命科学有限公司 治疗用合成寡核苷酸
EP1250152B1 (en) * 1999-12-28 2013-05-15 Bioniche Urology IP Inc. Synergistic composition containing hyaluronic acid in the treatment of cancer
LU90996B1 (en) * 2000-07-11 2003-01-08 Bayer Ag Use of the strains of the parapox ovis virus against fibrosis
CN100482275C (zh) * 2002-03-05 2009-04-29 细胞医药股份有限公司 固化的组织免疫佐剂
AU2003254792A1 (en) * 2002-08-02 2004-02-23 Sumitomo Pharmaceuticals Company, Limited Bacterial cell wall skeleton component preparaion
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
WO2005023277A1 (fr) * 2003-09-05 2005-03-17 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. Composition a la base de squelettes de parois de cellules de nocardia rouge procede de preparation et son utilisation therapeutique pour traiter l'erosion cervicale
CA2564180A1 (en) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. Pharmaceutical preparation containing bacterial cell wall skeleton component
EA032326B1 (ru) 2013-04-18 2019-05-31 Иммьюн Дизайн Корп. Монотерапия gla для применения в лечении рака
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
DK3158054T3 (da) 2014-06-17 2025-05-26 Crown Laboratories Inc Genetisk modificerede bakterier og fremgangsmåder til genetisk modifikation af bakterier
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
EP3668957A4 (en) * 2017-08-17 2021-06-02 University of Delaware Furan based compositions and methods of making thereof
CN116761582A (zh) 2020-06-23 2023-09-15 皇冠实验室有限公司 益生菌皮肤制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (enExample) * 1972-06-20 1973-12-27
FR2269962B1 (enExample) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000003724A1 (en) * 1998-07-16 2000-01-27 Hayashi, Akira Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
US7534443B1 (en) 1998-07-16 2009-05-19 Ichiro Azuma Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient

Also Published As

Publication number Publication date
DE3434766C2 (de) 1987-05-14
NO843776L (no) 1985-03-25
GB2149301A (en) 1985-06-12
KR870000843B1 (ko) 1987-04-25
DE3434766A1 (de) 1986-04-30
IN157240B (enExample) 1986-02-15
CH664897A5 (de) 1988-04-15
IT8448894A0 (it) 1984-09-24
ZA847405B (en) 1985-05-29
KR850002404A (ko) 1985-05-13
FI843716A7 (fi) 1985-03-24
FI843716A0 (fi) 1984-09-21
AU3340084A (en) 1985-03-28
FR2552326A1 (fr) 1985-03-29
DK446684A (da) 1985-03-24
AU566234B2 (en) 1987-10-15
FI843716L (fi) 1985-03-24
CA1244765A (en) 1988-11-15
NL8402902A (nl) 1985-04-16
HU192585B (en) 1987-06-29
HUT35521A (en) 1985-07-29
IL73034A (en) 1988-11-15
FR2552326B1 (fr) 1988-05-13
US4663306A (en) 1987-05-05
AT385659B (de) 1988-05-10
ES8608872A1 (es) 1986-07-16
GB8423993D0 (en) 1984-10-31
DK446684D0 (da) 1984-09-19
SE8404707D0 (sv) 1984-09-20
ATA302384A (de) 1987-10-15
IT1179444B (it) 1987-09-16
ES536167A0 (es) 1986-07-16
BE900650A (fr) 1985-03-21
NZ209635A (en) 1989-01-27
GB2149301B (en) 1988-06-22
SE8404707L (sv) 1985-03-24
JPS6254775B2 (enExample) 1987-11-17

Similar Documents

Publication Publication Date Title
JPS60120817A (ja) 医療用組成物
KR870000842B1 (ko) 정제 해독된 내독소 및 그의 제조방법
US4436728A (en) Refined detoxified endotoxin product
US4435386A (en) Refined detoxified endotoxin product
US4505900A (en) Refined detoxified endotoxin product
US4877611A (en) Vaccine containing tumor antigens and adjuvants
US4505899A (en) Refined detoxified endotoxin product
US4504473A (en) Pyridine soluble extract of a microorganism
US4613504A (en) Pyridine-soluble extracts of microorganisms
JPS6254774B2 (enExample)
JPH0556326B2 (enExample)
NZ204020A (en) Stable compositions containing cell wall skeleton and trehalose dimycolates
GB2104527A (en) Antigens as immunostimulant adjuvants
JPS5835121A (ja) 免疫刺激性補助剤からなる抗原及び免疫療法におけるその使用